• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

心血管医学记分卡。其影响及未来方向。

Scorecard cardiovascular medicine. Its impact and future directions.

作者信息

Topol E J, Califf R M

机构信息

Department of Cardiology, Cleveland Clinic Foundation, OH 44195.

出版信息

Ann Intern Med. 1994 Jan 1;120(1):65-70. doi: 10.7326/0003-4819-120-1-199401010-00011.

DOI:10.7326/0003-4819-120-1-199401010-00011
PMID:8250458
Abstract

Public release of operator-specific data for cardiovascular procedures has set a new precedent, introducing the "scorecard" era. Justification exists for public disclosure, but the mechanics of appropriate data release are complex from a clinical, statistical, and logistic standpoint. Scorecard medicine may appropriately promote regionalization of medical centers and consolidation of services, but unless the process is directed effectively, it may impair the development of new treatments because of a more restrictive clinical practice environment. We propose revamping our current system to facilitate rapid and accurate access to outcome data in the local practice environment so that improvement in practice occurs on a voluntary basis rather than in response to punitive restrictions. A rational plan needs to be developed for dealing with high-risk patients, perhaps through compensation in regression models used to calculate expected outcomes, and for the start-up of novice physicians. Special provisions are needed to promote clinical research. Before procedures are done, it would be ideal to provide a full disclosure informed consent, whereby the physician reports operator-specific data and the patient's decision-making process is facilitated. Overall, appropriate implementation of scorecards could ultimately lead to a substantial improvement in the quality of U.S. cardiovascular medicine.

摘要

心血管手术中特定术者数据的公开发布开创了一个新的先例,开启了“记分卡”时代。公开披露有其合理性,但从临床、统计和后勤角度来看,恰当的数据发布机制很复杂。记分卡医学可能会适当地促进医疗中心的区域化和服务整合,但除非有效引导这一过程,否则由于临床实践环境更具限制性,它可能会阻碍新治疗方法的发展。我们提议改进当前系统,以便在本地实践环境中快速准确地获取结果数据,从而使实践改进基于自愿而非应对惩罚性限制。需要制定一个合理的计划来处理高危患者,或许可以通过在用于计算预期结果的回归模型中进行补偿,以及针对新手医生的起步阶段。需要特殊规定来促进临床研究。在手术进行之前,提供一份全面披露的知情同意书是理想的做法,即医生报告特定术者数据,并促进患者的决策过程。总体而言,记分卡的恰当实施最终可能会大幅提高美国心血管医学的质量。

相似文献

1
Scorecard cardiovascular medicine. Its impact and future directions.心血管医学记分卡。其影响及未来方向。
Ann Intern Med. 1994 Jan 1;120(1):65-70. doi: 10.7326/0003-4819-120-1-199401010-00011.
2
Implementing a balanced scorecard as a strategic management tool in a long-term care organization.在长期护理机构中实施平衡计分卡作为一种战略管理工具。
J Health Serv Res Policy. 2008 Jan;13 Suppl 1:8-14. doi: 10.1258/jhsrp.2007.007013.
3
The NCI All Ireland Cancer Conference.美国国家癌症研究所全爱尔兰癌症会议。
Oncologist. 1999;4(4):275-277.
4
Report on financing the new model of family medicine.关于新型家庭医学模式融资的报告。
Ann Fam Med. 2004 Dec 2;2 Suppl 3(Suppl 3):S1-21. doi: 10.1370/afm.237.
5
[The origin of informed consent].[知情同意的起源]
Acta Otorhinolaryngol Ital. 2005 Oct;25(5):312-27.
6
Abortion and informed consent requirements.堕胎与知情同意要求。
Am J Obstet Gynecol. 1982 Sep 1;144(1):1-4. doi: 10.1016/0002-9378(82)90384-2.
7
Development of a pediatric cardiology quality improvement collaborative: from inception to implementation. From the Joint Council on Congenital Heart Disease Quality Improvement Task Force.儿科心脏病学质量改进协作组织的发展:从启动到实施。源自先天性心脏病质量改进联合委员会特别工作组。
Congenit Heart Dis. 2009 Sep-Oct;4(5):318-28. doi: 10.1111/j.1747-0803.2009.00328.x.
8
Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.日本作为超老龄化社会的领跑者:来自日本医学与医疗护理的视角
Geriatr Gerontol Int. 2015 Jun;15(6):673-87. doi: 10.1111/ggi.12450. Epub 2015 Feb 5.
9
ACCF/SCAI/AATS/AHA/ASE/ASNC/HFSA/HRS/SCCM/SCCT/SCMR/STS 2012 appropriate use criteria for diagnostic catheterization: a report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, Society for Cardiovascular Angiography and Interventions, American Association for Thoracic Surgery, American Heart Association, American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, Society for Cardiovascular Magnetic Resonance, and Society of Thoracic Surgeons.美国心脏病学会基金会适宜性使用标准专家组、心血管造影和介入学会、美国胸外科学会、美国心脏协会、美国超声心动图学会、美国核医学学会、美国心力衰竭学会、心律学会、重症医学会、心血管计算机断层扫描学会、心血管磁共振学会以及胸外科医师学会 2012 年诊断性心导管术适宜性使用标准:美国心脏病学会基金会适宜性使用标准专家组报告
J Am Coll Cardiol. 2012 May 29;59(22):1995-2027. doi: 10.1016/j.jacc.2012.03.003. Epub 2012 May 9.
10
Exception from informed consent: viewpoint of institutional review boards--balancing risks to subjects, community consultation, and future directions.知情同意的例外情况:机构审查委员会的观点——平衡对受试者的风险、社区咨询及未来方向
Acad Emerg Med. 2005 Nov;12(11):1050-5. doi: 10.1197/j.aem.2005.06.015.

引用本文的文献

1
Public reporting on cardiac electrophysiology procedures and outcomes: where are we now and where are we headed?心脏电生理手术及结果的公开报告:我们现在处于什么状况,又将走向何方?
J Interv Card Electrophysiol. 2019 Nov;56(2):137-141. doi: 10.1007/s10840-018-0400-9. Epub 2018 Jun 30.
2
Public reporting of PCI outcomes: for better or for worse.经皮冠状动脉介入治疗(PCI)结果的公开报告:有利有弊。
Curr Cardiol Rep. 2014 Jul;16(7):500. doi: 10.1007/s11886-014-0500-9.
3
Are high-quality cardiac surgeons less likely to operate on high-risk patients compared to low-quality surgeons? Evidence from New York State.
与低水平心脏外科医生相比,高水平心脏外科医生为高风险患者做手术的可能性更小吗?来自纽约州的证据。
Health Serv Res. 2008 Feb;43(1 Pt 1):300-12. doi: 10.1111/j.1475-6773.2007.00753.x.
4
Public disclosure of performance data: learning from the US experience.绩效数据的公开披露:借鉴美国经验
Qual Health Care. 2000 Mar;9(1):53-7. doi: 10.1136/qhc.9.1.53.
5
Advances in the medical management of acute coronary syndromes.
J Thromb Thrombolysis. 1999 Apr;7(2):171-89. doi: 10.1023/a:1008841721975.
6
Coronary artery bypass grafting in Canada: hospital mortality rates, 1992-1995.加拿大的冠状动脉搭桥术:1992 - 1995年的医院死亡率
CMAJ. 1998 Oct 20;159(8):926-30.
7
Toward improved coronary artery revascularization: is this as good as it gets?迈向更好的冠状动脉血运重建:这已经是最好的结果了吗?
CMAJ. 1998 Aug 11;159(3):237-8.
8
Maintaining standards in British and Canadian medicine: the developing role of the regulatory body.维持英国和加拿大的医学标准:监管机构不断演变的作用。
BMJ. 1998 Feb 28;316(7132):697-700. doi: 10.1136/bmj.316.7132.697.
9
A breast cancer care report card. An assessment of performance and a pursuit of value.一份乳腺癌护理成绩单。绩效评估与价值追求。
West J Med. 1997 Apr;166(4):248-52.
10
Clinical audit: time for a reappraisal?临床审计:是时候重新评估了吗?
J R Coll Physicians Lond. 1996 Sep-Oct;30(5):415-25.